	Capital Social Ordinario		Fecha
AbbVie	USD 1.77B	1.75B	2025-06
Acadia Pharmaceuticals	USD 168.71M	104K	2025-09
Agios Pharmaceuticals	USD 58.45M	169K	2025-12
Alnylam Pharmaceuticals	USD 132.38M	585K	2025-12
Amgen	USD 539M	1000K	2025-12
Arrowhead Research	USD 135.7M	2.44M	2025-09
Biogen	USD 146.7M	200K	2025-09
BioMarin Pharmaceutical	USD 192.3M	201K	2025-12
Bristol-Myers Squibb	USD 2.04B	1.74B	2025-09
Gilead Sciences	USD 1.24B	1000K	2025-12
Incyte	USD 198.46M	2.33M	2025-12
Insmed	USD 214.26M	1.67M	2025-12
Ionis Pharmaceuticals	USD 161.14M	160.98M	2025-09
J&J	USD 2.41B	584K	2025-09
Merck	USD 2.49B	15.79M	2025-09
Moderna	USD 391M	2M	2025-09
Neurocrine Biosciences	USD 100.1M	400K	2025-12
Novartis	USD 1.94B	23.4M	2025-06
Pfizer	USD 5.69B	1000K	2025-09
PTC Therapeutics	USD 81.47M	1.54M	2025-12
Puma Biotechnology	USD 5K	0	2024-06
Regeneron Pharmaceuticals	USD 105.3M	1.1M	2025-09
Roche Holding	CHF 795.62M	699.54K	2025-12
Sarepta Therapeutics	USD 104.77M	7.06M	2025-09
Ultragenyx Pharmaceutical	USD 96.44M	88K	2025-09
United Therapeutics	USD 42.9M	42.1M	2025-09
Vertex Pharmaceuticals	USD 254M	0	2025-12

Vertex Pharmaceuticals Capital Social Ordinario - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Feb 2026.